Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?

American Heart Journal

Volumn 151, Issue 3, 2006, Pages 712.e1-712.e7

  Kragelund, Charlotte ^a,b   Grønning, Bjørn ^a   Omland, Torbjørn ^b   Køber, Lars ^c   Strande, Søren ^c   Steffensen, Rolf ^d   Hildebrandt, Per ^a  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c Rigshospitalet   (Denmark)

^d HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

N TERMINAL PROBRAIN NATRIURETIC PEPTIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PEPTIDE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RADIODIAGNOSIS; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

EID: 33344468706     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.12.009     Document Type: Article

References (34)

1. J.A. de Lemos, D.K. McGuire, and M.H. Drazner B-type natriuretic peptide in cardiovascular disease Lancet 362 2003 316 322
2. C.M. Wei, D.M. Heublein, and M.A. Perrella Natriuretic peptide system in human heart failure Circulation 88 1993 1004 1009
3. T. Omland, A. Aakvaag, and V.V. Bonarjee Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
4. C. Kragelund, B. Gronning, and L. Kober N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease N Engl J Med 352 2005 666 675
5. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
6. J.P. Goetze, C. Christoffersen, and M. Perko Increased cardiac BNP expression associated with myocardial ischemia FASEB J 17 2003 1105 1107
7. K. Bibbins-Domingo, M. Ansari, and N.B. Schiller B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study Circulation 108 2003 2987 2992
8. M.S. Sabatine, D.A. Morrow, and J.A. de Lemos Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia J Am Coll Cardiol 44 2004 1988 1995
9. V.H. Casco, J.P. Veinot, and M.L. Kuroski de Bold Natriuretic peptide system gene expression in human coronary arteries J Histochem Cytochem 50 2002 799 809
10. M. Weber, T. Dill, and R. Arnold N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris Am Heart J 148 2004 612 620
11. T. Nishikimi, Y. Mori, and K. Ishimura Association of plasma atrial natriuretic peptide, n-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function*1 Am J Med 116 2004 517 523
12. S. Sadanandan, C.P. Cannon, and K. Chekuri Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol 44 2004 564 568
13. H.T. Dodge, and F.H. Sheehan Quantitative contrast angiography for assessment of ventricular performance in heart disease J Am Coll Cardiol 1 1983 73 81
14. B.C. Solymoss, M.G. Bourassa, and L. Campeau Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity Am J Cardiol 93 2004 159 164
15. R.M. Califf, H.R. Phillips III, and M.C. Hindman Prognostic value of a coronary artery jeopardy score J Am Coll Cardiol 5 1985 1055 1063
16. F. Gustafsson, J. Badskjær, and F. Steensgaard Value of N-terminal proBNP in the diagnosis of left ventricular systolic dysfunction in primary care patients referred for echocardiography Heart Drug 3 2003 141 146
17. D.L. Simel, G.P. Samsa, and D.B. Matchar Likelihood ratios with confidence: sample size estimation for diagnostic test studies J Clin Epidemiol 44 1991 763 770
18. G. Ndrepepa, S. Braun, and J. Mehilli Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction Am J Cardiol 95 2005 553 557
19. J.A. de Lemos, D.A. Morrow, and J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
20. T. Omland, A. Persson, and L. Ng N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918
21. T. Omland, A.M. Richards, and R. Wergeland B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease Am J Cardiol 95 2005 24 28
22. C. Kistorp, I. Raymond, and F. Pedersen N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults JAMA 293 2005 1609 1616
23. P. Gaede, P. Hildebrandt, and G. Hess Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria Diabetologia 48 2005 156 163
24. M.H. Olsen, K. Wachtell, and C. Tuxen N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study J Hypertens 22 2004 1597 1604
25. K. Kikuta, H. Yasue, and M. Yoshimura Increased plasma levels of B-type natriuretic peptide in patients with unstable angina Am Heart J 132 1 Pt 1 1996 101 107
26. P.R. Kalra, A. Gomma, and C. Daly Reduction in plasma concentrations of N terminal pro B type natriuretic peptide following percutaneous coronary intervention Heart 90 2004 1334 1335
27. M. Toth, K.H. Vuorinen, and O. Vuolteenaho Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium Am J Physiol 266 4 Pt 2 1994 H1572 H1580
28. J. Tateishi, M. Masutani, and M. Ohyanagi Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty Clin Cardiol 23 2000 776 780
29. S.P. D'Souza, D.M. Yellon, and C. Martin B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening Am J Physiol Heart Circ Physiol 284 2003 H1592 H1600
30. C. Mueller, A. Scholer, and K. Laule-Kilian Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea N Engl J Med 350 2004 647 654
31. B.A. Groenning, I. Raymond, and P.R. Hildebrandt Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population Heart 90 2004 297 303
32. M.M. Redfield, R.J. Rodeheffer, and S.J. Jacobsen Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study Circulation 109 2004 3176 3181
33. K. Bibbins-Domingo, M. Ansari, and N.B. Schiller Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study Am J Med 116 2004 509 516
34. T. Omland, A. Aakvaag, and H. Vik-Mo Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment Heart 76 1996 232 237